billHR2936Event Thursday, April 17, 2025Analyzed

Addressing Boarding and Crowding in the Emergency Department

Neutral
Impact4/10

Summary

The ABC-ED Act of 2025 (HR2936) is in early committee stages, proposing to expand public health data modernization grants for tracking hospital bed capacity and emergency department metrics. While this could create demand for healthcare data analytics and IT services, the bill does not authorize specific funding, and its passage is uncertain. Current market data shows mixed performance for technology companies that could potentially benefit.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR2936 is in early committee stages and does not authorize specific funding, limiting immediate market impact.
  • 2.The bill aims to expand public health data modernization grants to include hospital bed capacity and emergency department metrics, potentially creating demand for healthcare IT and data analytics.
  • 3.Technology companies like Oracle, Microsoft, Alphabet, IBM, and Dell Technologies could be structural beneficiaries if the bill passes and receives appropriations.

Market Implications

The ABC-ED Act of 2025 (HR2936) is an early-stage bill that, if enacted and funded, could generate new demand for healthcare data analytics and IT solutions. Companies such as Oracle ($ORCL), Microsoft ($MSFT), Alphabet ($GOOGL), IBM ($IBM), and Dell Technologies ($DELL) are positioned to compete for such contracts. However, the bill currently authorizes no specific funding, meaning any market impact is contingent on future appropriations. Recent market performance for these technology companies is mixed, with Dell Technologies ($DELL) showing strong short-term gains, while Oracle ($ORCL) and Microsoft ($MSFT) have seen declines over the past 30 days.

Full Analysis

The Addressing Boarding and Crowding in the Emergency Department Act of 2025 (HR2936) was introduced in the House on April 17, 2025, and subsequently referred to the Committees on Energy and Commerce and Ways and Means. This bill aims to amend the Public Health Service Act to allow public health data modernization grants to be used for tracking hospital bed capacity and related emergency department metrics, including wait times and offload times for emergency medical services. It also proposes establishing public-facing dashboards for this information. The bill's mechanism involves expanding the permissible uses of existing public health data modernization grants. It does not authorize new funding amounts, meaning any potential demand for technology and services would depend on the allocation of existing or future appropriations for these grants. The bill's current status as 'Referred to committee' indicates it is in the early stages of the legislative process, and its ultimate passage is not guaranteed. A companion bill, S1974, has been introduced in the Senate, which could indicate broader legislative interest. Structural beneficiaries, should this bill advance and receive appropriations, would include technology companies specializing in healthcare data analytics, IT infrastructure, and software development for data tracking and dashboard creation. Companies like Oracle ($ORCL), Microsoft ($MSFT), Alphabet ($GOOGL), IBM ($IBM), and Dell Technologies ($DELL) possess the capabilities to provide such services and hardware. However, without specific funding authorization, the direct market impact remains speculative. Looking at recent market data, Oracle ($ORCL) is trading at $141.91, down 3.53% over the last 7 days and 7.22% over the last 30 days. Microsoft ($MSFT) is at $369.48, with a slight 7-day decrease of 0.19% and a 30-day decrease of 9.65%. Alphabet ($GOOGL) shows positive momentum at $300.91, up 4.64% over 7 days and 0.8% over 30 days. IBM ($IBM) is at $243.60, up 0.5% in 7 days but down 5.89% in 30 days. Dell Technologies ($DELL) is at $175.67, showing strong gains of 7.02% in 7 days and 19.92% in 30 days. The mixed performance across these technology companies indicates that the potential for future demand from this bill is not currently a primary driver of their stock movements. The next legislative steps involve committee consideration and potential markups in both the House and Senate.

Market Impact Score

4/10
Minimal ImpactModerateMajor Market Event

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderApr 18, 2026

Accelerating Medical Treatments for Serious Mental Illness

This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.